Effects of Flecainide in Patients With New SCN5A Mutation
- 11 April 2000
- journal article
- other
- Published by Wolters Kluwer Health in Circulation
- Vol. 101 (14) , 1698-1706
- https://doi.org/10.1161/01.cir.101.14.1698
Abstract
Background—Mutations in the cardiac sodium channel gene (SCN5A) can cause one variant of the congenital long-QT syndrome. The effects of some of these mutations on the α-subunit channel properties ...Keywords
This publication has 21 references indexed in Scilit:
- Right bundle branch block, persistent ST segment elevation and sudden cardiac death: A distinct clinical and electrocardiographic syndrome: A multicenter reportPublished by Elsevier ,2010
- Mutations in the hminK gene cause long QT syndrome and suppress lKs functionNature Genetics, 1997
- Gene-Specific Therapy for Long QT Syndrome.Annals of Noninvasive Electrocardiology, 1997
- Pharmacological targeting of long QT mutant sodium channels.Journal of Clinical Investigation, 1997
- Electrophysiological and pharmacological correspondence between Kv4.2 current and rat cardiac transient outward currentCardiovascular Research, 1997
- Local anesthetics as effectors of allosteric gating. Lidocaine effects on inactivation-deficient rat skeletal muscle Na channels.Journal of Clinical Investigation, 1996
- Assignment of the human heart tetrodotoxin-resistant voltage-gated Na+ channel α-subunit gene (SCN5A) to band 3p21Cytogenetic and Genome Research, 1995
- Evidence of Genetic Heterogeneity in the Long QT SyndromeScience, 1993
- Linkage of a Cardiac Arrhythmia, the Long QT Syndrome, and the Harvey ras -1 GeneScience, 1991
- Voltage- and time-dependent depression of maximum rate of depolarisation of guinea-pig ventricular action potentials by two new antiarrhythmic drugs, flecainide and lorcainideCardiovascular Research, 1983